Linchuang shenzangbing zazhiA rising incidence of acute kidney injury (AKI) may lead to longer hospitalization stays and even greater mortality. Diabetes is an independent risk factor for AKI and using hypoglycemic agents has been a fundamental glycemic control in diabetics ...
Dan-ning Guo +2 more
doaj +1 more source
Ethnomedicinal survey of traditional antidiabetic plants in Baturraden and Sumbang
Medisains, 2020 Background: The scientific-based jamu development program enables the development of medicinal plants in the traditional medicine system that eventual-ly can be used in the formal healthcare system.
Wahyu Utaminingrum +2 more
doaj +1 more source
Comparative study of the hypoglycemic and biochemical effects of Catharanthus roseus (Linn) g. apocynaceae (Madagascar periwinkle) and chlorpropamide (diabenese) on alloxan-induced diabetic rats [PDF]
, 2005 The effect of the aqueous extracts of Catharanthus roseus and chlorpropamide (Diabenese) on the levels of serum cholesterol, total protein, lipid peroxidation, blood glucose and liver enzymes were compared in alloxan-induced diabetic rats.
Iweala, E. E. J., Okeke, C. U.
core +1 more source
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine [PDF]
, 2019 Type 2 diabetes mellitus (T2DM) is a chronic disease that has reached the levels of a global epidemic. In order to achieve optimal glucose control, it is often necessary to rely on combination therapy of multiple drugs or insulin because uncontrolled ...
Andreozzi, F, Mannino, Gc, Sesti, G
core +1 more source
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study [PDF]
, 2018 Introduction: DPP-4 inhibitors (DPP4i) and sulfonylureas are popular second-line therapies for type 2 diabetes (T2D), but there is a paucity of real-world studies comparing their effectiveness in routine clinical practice. Methods: This was a multicenter
Avogaro Angelo +10 more
core +1 more source
Diabetology & Metabolic Syndrome, 2014 BackgroundThe oral DPP-4 inhibitors are new incretin-based therapies for treatment of type 2 diabetes. To assess the efficacy and safety of three DPP-4 inhibitors (Saxagliptin, Sitagliptin and Vildagliptin) as add-on therapy to dual combination of ...
Chun-jun Li +6 more
semanticscholar +1 more source
Oral antidiabetic for the metabolic control in gestational diabetes
Acta Médica del Centro, 2016 The search for alternative therapies to insulin for the treatment of gestational diabetes goes back to studies from the decade of 1970 and 1980. The oral hypoglycemic agents have emerged as an effective alternative for metabolic control of gestational ...
Yoany Marín Tápanes +1 more
doaj
Non-obese adult onset diabetes with oral hypoglycemic agent failure: islet cell autoantibodies or reversible beta cell refractoriness? [PDF]
, 2003 Pancreatic ß cell function and insulin sensitivity, analyzed by the homeostasis model assessment, before and after 24 weeks of insulin therapy were studied and correlated with the presence of autoantibodies against ß cells (islet cell and anti-glutamic ...
Aguade, Luiz Carlos Muria +6 more
core +2 more sources
DIRECT HEALTHCARE COSTS OF DIABETES MELLITUS PATIENTS IN SPAIN [PDF]
Objectives. To estimate the healthcare resources spent by diabetic patients in Spain during the year 2002. Methods. The present work is a cost-of-illness study.
Begoña Molina +3 more
core
The outcome of Gestational Diabetic pregnancies in the Maltese Islands [PDF]
, 2004 Gestational diabetes is generally associated with a higher morbidity and mortality for both the mother and child. Aims: The study aims to assess the outcome indicators of women suffering gestational diabetes and compare these to the remaining obstetric ...
Azzopardi, Joseph +4 more
core